Resultados do filtro
Resultados do filtro
General (55) Acquisitions (4) New Products (4) New Technologies (1) Partnerships (1)
2022 (3) 2021 (5) 2020 (5) 2019 (21) 2018 (18) 2017 (4) 2016 (2) 2015 (1)
English (59)
EnglishX
Showing 1‐10 of 59
Comunicado de imprensa
01 Nov 2022
Lonza Launches New Capsule to Deliver Acid-Sensitive Active Pharmaceutical Ingredients to the Intestine
Lonza meets pressing market need by launching first ever coating-free capsule to support intestinal delivery of acid-sensitive APIs Innovative Capsugel® Enprotect™ capsule can...
Comunicado de imprensa
09 Mai 2022
Lonza Expands its Capsugel® Capsule Offering to Include Titanium Dioxide-Free White Hard Gelatin Capsules
New hard gelatin capsule provides a bright white color, while meeting titanium dioxide-free requirements for foods in the European Union The new capsule features an...
Comunicado de imprensa
23 Mar 2022
Christian Seufert apontado presidente da divisão de Cápsulas e Ingredientes de Saúde
Lonza appoints Christian Seufert as President of the CHI Division and member of the Executive Committee Christian brings a unique level of experience and expertise from a...
Comunicado de imprensa
30 Jun 2021
Kaged Muscle a primeira a lançar com a Lonza o TWK10 Sports Probiotic nos Estados Unidos
Kaged Muscle is dedicated to providing premium sports nutrition supplements featuring high-quality, science-backed ingredientsTWK10® sports probiotic, brought to market by...
Comunicado de imprensa
28 Abr 2021
New Study Shows Lonza’s Carniking® Premix Improves Protein Turnover, Maximum Energy Expenditure in Active Dogs
Recently published research shows that Carniking® premix improves lean muscle mass and supports efficient energy expenditure in active dogs
Comunicado de imprensa
20 Abr 2021
Clinically Proven UC-II ® Undenatured Type II Collagen Made with Organic Collagen is Now Available for the US Organic Joint-Health Market
Quote from Martin Sambusini, Associate Director of Innovation, Lonza Capsules & Health Ingredients:“Right now, joint health is a key priority...
Comunicado de imprensa
01 Abr 2021
A Lonza conclui o desinvestimento de dois centros para a NextPharma
Completion of sale of Lonza sites in Ploermel (FR) and Edinburgh (UK)A seamless ownership transfer process remains a priorityA French version of this release is also availableQuote...
Comunicado de imprensa
19 Jan 2021
NextPharma irá adquirir dois centros da Lonza especializados em formas farmacêuticas orais lipídicas
Agreement initiates process for future acquisition of Lonza sites in Ploermel (FR) and Edinburgh (UK) allowing NextPharma to broaden technology offering into lipid finished dosage...
Comunicado de imprensa
17 Dez 2020
Body&Fit to Utilize Lonza's Comprehensive Capsule and Specialty Ingredients Portfolio to Expand Product Offering
Glanbia Performance Nutrition's direct-to-customer division Body&Fit to utilize Lonza's Duocap® capsule technologyBody&Fit plans to launch new products featuring Lonza's...
Comunicado de imprensa
22 Out 2020
Lonza amplia sua capacidade de fabricação de cápsulas
Investment of CHF85m will expand capsule manufacturing capacity by 30 billion capsules annuallyThe new expansion involves eight global Lonza sitesThe investment aims to address the...
1 2 3 4 ... 6 >